Entity seeks official data to support self-regulation and prepare the sector for future regulation

The initiative prepares future healthcare professionals with practice, science, and responsibility

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

Patients with ASD, fibromyalgia, and chronic pain will be able to access cannabidiol-based medications through the public network

The substitute was unanimously approved by the deputies

Proper storage of cannabis-based products can extend their shelf life by up to two years. Understand the best practices to keep your medication in ideal conditions and avoid losing therapeutic properties.

Data analysis tool mapped 39 plantations across the country

International and national experts gather in São Paulo to deepen discussions and research on the use for treatment in various specialties

Four experts report on the various experiences of cultivating cannabis for medicinal and industrial purposes in Brazil and abroad, mapping best practices and the main difficulties for the development of the activity

Individuals with Attention Deficit Hyperactivity Disorder (ADHD) who consume medicinal cannabis tend to use fewer prescribed medications, including dependency-causing psychostimulants

Sechat has developed a guide to help you file an HC in court

The change in federal legislation recognizes the medical use of cannabis, but does not alter the rules for recreational consumption or the national prohibition

Event opens deadline for submission of scientific abstracts in oral presentation and poster formats

The National Narcotics Fund (FNE) will no longer require Export Certificates for shipments destined to patients (Individuals) in Brazil, eliminating a bureaucratic obstacle that hindered the flow of derivatives between the two countries

Companies report delays in the release of shipments, while official data from Anvisa indicates reduced average timelines and a high approval rate

Doctor Beatriz Milani explains how the principle “Start low, go slow” guides the safe and personalized use of medicinal cannabis, ensuring careful adjustments and the lowest effective dose for each patient

Decision from the 2nd Federal Court of Guarulhos determines that authorities do not seize oil, cannabis flowers, and vaporizer used in medical treatment by Argentine patient.

Tickets for the first batch of the Brazilian Medicinal Cannabis Congress are still available for R$ 540.00; turnover to the second batch takes place on December 16

Event brings together experts from ex-Anvisa, Embrapa, and state government to discuss from medical prescription to agricultural potential of hemp

Initiative "Popular Education - Cannabis-CIM" will offer workshops and podcasts for patients, caregivers, and healthcare professionals in partnership with associations